Search research articles
Contact Us
Filters
Showing results (321-330 of 383) with videos related to
Page
of 39
Sort By:
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
January 29, 2021
Patient and Physician Satisfaction with Telehealth During the COVID-19 Pandemic: Sports Medicine Perspective
David J Kirby, Jordan W Fried, Daniel B Buchalter, et al.
Gastroenterology
|
August 8, 2006
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
Hari S Conjeevaram, Michael W Fried, Lennox J Jeffers, et al.
Alimentary Pharmacology & Therapeutics
|
October 25, 2021
Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis
Hannah P Kim, Michael O Idowu, Andrea R Mospan, et al.
American Journal of Epidemiology
|
May 20, 2017
Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B
Mohamed A Hassan, W Ray Kim, Ruosha Li, et al.
Journal of Virology
|
March 9, 2000
Sequence heterogeneity of TT virus and closely related viruses
Y E Khudyakov, M E Cong, B Nichols, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 26, 2011
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C
Sarah J Schrieber, Roy L Hawke, Zhiming Wen, et al.
Gastroenterology
|
June 16, 2010
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction
Alexander J Thompson, Jacques Fellay, Keyur Patel, et al.
Alimentary Pharmacology & Therapeutics
|
January 30, 2018
Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy
D M Evon, J Amador, P Stewart, et al.
Journal of Hepatology
|
June 25, 2003
Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis C
Stefan Zeuzem, E Jenny Heathcote, Mitchell L Shiffman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 12, 2019
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection
Mayur Brahmania, Manuel Lombardero, Bettina E Hansen, et al.
Page
of 39
Search research articles
Search
Showing results (321-330 of 383) with videos related to
Sort By:
Page
of 39
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
January 29, 2021
Patient and Physician Satisfaction with Telehealth During the COVID-19 Pandemic: Sports Medicine Perspective
David J Kirby, Jordan W Fried, Daniel B Buchalter, et al.
Gastroenterology
|
August 8, 2006
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
Hari S Conjeevaram, Michael W Fried, Lennox J Jeffers, et al.
Alimentary Pharmacology & Therapeutics
|
October 25, 2021
Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis
Hannah P Kim, Michael O Idowu, Andrea R Mospan, et al.
American Journal of Epidemiology
|
May 20, 2017
Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B
Mohamed A Hassan, W Ray Kim, Ruosha Li, et al.
Journal of Virology
|
March 9, 2000
Sequence heterogeneity of TT virus and closely related viruses
Y E Khudyakov, M E Cong, B Nichols, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 26, 2011
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C
Sarah J Schrieber, Roy L Hawke, Zhiming Wen, et al.
Gastroenterology
|
June 16, 2010
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction
Alexander J Thompson, Jacques Fellay, Keyur Patel, et al.
Alimentary Pharmacology & Therapeutics
|
January 30, 2018
Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy
D M Evon, J Amador, P Stewart, et al.
Journal of Hepatology
|
June 25, 2003
Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis C
Stefan Zeuzem, E Jenny Heathcote, Mitchell L Shiffman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 12, 2019
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection
Mayur Brahmania, Manuel Lombardero, Bettina E Hansen, et al.
Page
of 39